Author: healthadmin

When Vanessa Carter was 25 years old, she was involved in a devastating car accident in Johannesburg. It broke all the bones on the right side of her face and led to a years-long journey through multiple reconstructive surgeries. Six years later, Carter received a prosthetic implant to reconstruct his cheekbone. Perhaps her worst ordeal was over. But one day she noticed pus oozing from her face. It was an infection. And almost a year later, it hasn’t gone away. “I was taking antibiotics and seeing doctors, but no one answered me,” she told DW. “And all this time, this…

Read More

Drugs such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) are revolutionizing the treatment of obesity, but without affordable, healthy food and the right support, health inequalities in the UK could widen, say researchers at UCL and the University of Cambridge. In a communication published in natural medicineresearchers argue that incretin-based treatments, also known as weight-loss drugs, have revolutionized obesity treatment, but their long-term effects may depend on factors beyond the drugs themselves. Access to nutritional advice, healthy foods and ongoing medical support are all likely to influence whether patients are able to use medicines safely and maintain improved health outcomes over…

Read More

Get the health information and medications you need every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Hello, Morning Round readers! It’s officially June, my birthday month. Stop, stop, everyone hurry up and wish me a happy birthday! There’s a lot to cover today, including news from our world – the pharmaceutical industry, how much future GLP-1 drugs will cost the Medicare program, and the latest on Ebola from Helen Branswell, Danielle Payne and Chelsea Siluzzo. Trump administration proposes overhaul of subsidy granting process The Trump administration has announced a sweeping proposal to overhaul bedrock regulations on all…

Read More

AstraZeneca is refining the rationale for Imfinzi (durvalumab) and Imjud (tremelimumab) combination therapy in liver cancer, announcing new Phase 3 results from the Emerald trial program evaluating the immunotherapy duo in a locoregional setting. The Phase 3 Emerald 3 study, presented June 1 at the 2026 Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, positions AZ’s Imfinzi/Imjud therapy as an “attractive treatment option” for patients with unresectable embolization-eligible hepatocellular carcinoma (HCC), ASCO expert Vishwanath Satyanarayanan, MD, commented in an ASCO press release. In a three-arm study of 760 patients, the company combined its PD-L1 antibody Imfinzi and anti-CTLA-4 antibody…

Read More

Researchers at Massachusetts General Brigham have found evidence that the thymus, a small immune system organ long thought to lose its importance after childhood, may play a major role in adult health. Two new studies have found that adults with healthy thymuses are more likely to live longer and less likely to develop serious illnesses. This study also suggests that thymic health may influence cancer patients’ response to immunotherapy. The findings were published in two papers in the same issue. nature and challenges decades-old assumptions about the thymus. The results indicate that this organ remains important throughout adulthood and may…

Read More

When we audited the response of chatbots in the health and medical field, where incorrect information is easily disseminated, we found that 49.6% of responses had problems. Specifically, 30% said it was “somewhat problematic” and 19.6% said it was “very problematic.” Each chatbot asked 10 questions from five categories: cancer, vaccines, stem cells, nutrition, and athletic performance. The paper is BMJ Open. Artificial intelligence systems have experienced rapid development in recent years, moving from relatively rudimentary algorithms to large-scale language models that can communicate with users using natural language. Because they can communicate with humans in their own language, these…

Read More

TSylvia lives with her three children in a Western Cape township on the outskirts of Cape Town.Every summer, the brick house that Sylvia lives in with her three children becomes so unbearably hot that her youngest child cries and her two older children struggle to concentrate on their homework. According to a recent report in The Lancet, Sylvia is not alone. “In 2024, South Africans were exposed to an average of 13 days of heatwaves, of which 10.5 days (80%) would not have been predicted to occur in the absence of climate change.”But now that the asbestos roof has been…

Read More

Health tech startup Enzo Health has touted its AI-native electronic health record (EHR) system designed for home health agencies as an industry first. The end-to-end agent system, called Enzo EHR, automates the entire patient episode, according to the company. Product news first provided to Fierce Healthcare. When Enzo Health CEO and co-founder Zach Newman transitioned into home care, he was shocked by the current processes and systems across the industry. “I couldn’t believe the system that people were working in,” Newman said in an interview with Fierce Healthcare. “And the manual labor and labor that was required outside of that…

Read More

NASA’s Nancy Grace Roman Space Telescope is expected to dramatically expand the search for planets outside our solar system, known as exoplanets. Scientists estimate that the mission will discover about 100,000 previously unknown worlds, a significant increase compared to the approximately 6,300 exoplanets discovered to date through NASA missions and other observatories. What’s especially exciting about Roman is where it shows up. Most exoplanet discoveries to date have come from relatively nearby regions of the galaxy. However, Roman will explore a largely unexplored region of the Milky Way galaxy and provide a broader view of planetary systems across the galaxy.…

Read More